Josh Rabinowitz

Josh came to NJOY on a leave of absence from Princeton University, where he is a full professor in the Department of Chemistry and the Lewis-Sigler Institute for Integrative Genomics.

Dr. Rabinowitz received both an M.D. and Ph.D. from Stanford University. Thereafter, he co-founded Alexza Pharmaceuticals, where he invented the Adasuve Inhaler for treatment of acute agitation, an FDA-approved inhalation drug product.

Dr. Rabinowitz is an inventor of more than 130 U.S. Patents and author of over 110 major journal articles, including seven in the past four years in Science or Nature. At NJOY, Dr. Rabinowitz is responsible for all science-related aspects of the business, including the laboratory and clinical testing of NJOY products, and oversight of product manufacturing and quality control.

Josh Rabinowitz is the Chief Scientist at NJOY, based in United States, North America. With a background in Lifestyle, Josh Rabinowitz has a rich history of leadership and innovation.Josh Rabinowitz studied MD unknown at Stanford University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.